Back to Search
STEVE TRUDEL, PHARMD
PHARMD
Pharmacist
NPI: 1629309653Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PS33702(FL)
Research & Publications (20)
Magnetic frustration and spin disorder in isostructural M(mu-OH2)2[Au(CN)2]2 (M = Mn, Fe, Co) coordination polymers containing double aqua-bridged chains: SQUID and microSR studies.
PMID 19053335·Inorg Chem·2009
8-other
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma.
PMID 18754030·Leukemia·2009
7-preclinical
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.
PMID 19225538·Leukemia·2009
3-trial
Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.
PMID 19562038·PLoS One·2009
7-preclinical
Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant.
PMID 19450753·Biol Blood Marrow Transplant·2009
8-other
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.
PMID 18271526·J Proteome Res·2008
8-other
A closer look: magnetic behavior of a three-dimensional cyanometalate coordination polymer dominated by a trace amount of nanoparticle impurity.
PMID 18666297·Chemistry·2008
8-other
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma.
PMID 18645194·J Clin Oncol·2008
3-trial
Oncolytic virotherapy for multiple myeloma using a tumour-specific double-deleted vaccinia virus.
PMID 18509356·Leukemia·2008
8-other
Cyproheptadine displays preclinical activity in myeloma and leukemia.
PMID 18502826·Blood·2008
7-preclinical
Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway.
PMID 16888648·Cell Death Differ·2007
7-preclinical
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.
PMID 17875808·Blood·2007
7-preclinical
Quantitative analysis of a proteome by N-terminal stable-isotope labelling of tryptic peptides.
PMID 17659651·Rapid Commun Mass Spectrom·2007
7-preclinical
Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution.
PMID 17568814·Leukemia·2007
8-other
High sensitivity identification of membrane proteins by MALDI TOF-MASS spectrometry using polystyrene beads.
PMID 17355127·J Proteome Res·2007
7-preclinical
Expression and mutation status of candidate kinases in multiple myeloma.
PMID 17344920·Leukemia·2007
8-other
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma.
PMID 17332241·Blood·2007
8-other
The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
PMID 17255285·Clin Cancer Res·2007
7-preclinical
Membrane cholesterol content modulates ClC-2 gating and sensitivity to oxidative stress.
PMID 17110372·J Biol Chem·2007
7-preclinical
MIP-1alpha (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma.
PMID 16849642·Blood·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7305 N MILITARY TRL
RIVIERA BEACH, FL 33410 - Phone
- (561) 422-8262
Quick Facts
- NPI
- 1629309653
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile